David: I said communications with investors were poor? I really meant virtually non-existent.
This has been a problem for a long time, and I think I know where the responsibility lies (lays? I don't know, I could never figure this one out).
I believe that the product is good, but I also believe that the company can only be successful if it refashions itself to reflect the way that successful biotech companies work. I am anxiously awaiting word on new appointments--and I sincerely hope the BOD is doing its homework, because we will not survive another Gang of 2.
As far as making it through Jan., I'll take the bet. If they're still here on Feb. 1, you owe me one doughnut, and I aims to collect.
Happy New Year, and a healthy one too. MA
